Kesters Pharma Invest SRL
Kesters Pharma Invest reported total assets of 469,134 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Apr 2026).
The score of Kesters Pharma Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kesters Pharma Invest's annual accounts
| 2025 | |
|---|---|
| Net result | 36,924 € |
| Equity | 39,624 € |
| Cash | 29,545 € |
| EBITDA | 51,798 € |
| Total assets | 469,134 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Apr 2026
Kesters Pharma Invest's financial analysis
- Solvency8.4%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kesters Pharma Invest
Kesters Pharma Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1025.025.031
- VAT number
- BE1025025031
- Peppol
- Registered · 0208:1025025031 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Jul 2025
- Registered office
- 3530 Houthalen-Helchteren
- Latest accounts
- 2025 · filed on 09 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Kesters Pharma Invest (SRL) has been based in Houthalen-Helchteren since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 36,924 € and equity of 39,624 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Kesters Pharma Invest
Companies in the same business, of comparable size and area, outside its group.
- Apone Retail sale of pharmaceutical products Hemiksem · balance sheet 653,679 €
- VdC Invest Retail sale of pharmaceutical products Lierde · balance sheet 660,114 €
- Meli Pharm Retail sale of pharmaceutical products Schaerbeek · balance sheet 224,525 €
- Apkpharma Retail sale of pharmaceutical products Manage · balance sheet €1.05m
- geroFarma Retail sale of pharmaceutical products Kortrijk · balance sheet €1.05m
- Camba-Pharma Retail sale of pharmaceutical products Ghent · balance sheet 437,825 €
- Apotheek De Boeck Retail sale of pharmaceutical products Lierde · balance sheet €1.30m
- Duchi-Naert Retail sale of pharmaceutical products Harelbeke · balance sheet €1.52m
Frequently asked questions about Kesters Pharma Invest
What is the revenue of Kesters Pharma Invest?
Kesters Pharma Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kesters Pharma Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE1025025031 for Kesters Pharma Invest, if the company is VAT-registered. Its company number (CBE) is 1025.025.031.
Where is the registered office of Kesters Pharma Invest?
According to the CBE register, the registered office of Kesters Pharma Invest is in 3530 Houthalen-Helchteren.
What is the equity of Kesters Pharma Invest?
At the close of the 2025 financial year, the equity of Kesters Pharma Invest amounts to 39,624 €, a solvency of 8.4% of total assets.
Who manages Kesters Pharma Invest?
The register lists 2 active mandates at Kesters Pharma Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Kesters Pharma Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →